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Understandinghowchromatinmodification regulates
development and disease can be limited by available
material. Despite recent progress, balancing high-
quality and reliable mapping using chromatin-immu-
noprecipitation-based deep sequencing (ChIP-seq)
remains a challenge. We report two techniques, re-
covery via protection (RP)-ChIP-seq and favored
amplification RP-ChIP-seq (FARP-ChIP-seq), that
provide reproducible mapping in as few as 500 cells.
RP-ChIP-seq allows detection of age-associated
epigenetic changes in a single mouse lens, whereas
FARP-ChIP-seq accurately maps histone H3 lysine
4 trimethylation (H3K4me3) and H3K27me3 in long-
term hematopoietic stem cells (LT-HSCs), short-
term HSCs (ST-HSCs), and multi-potent progenitors
(MPPs) from one mouse. These datasets not only
highlight genes that may be involved in lens aging
but also indicate a lack of H3K4me3/H3K27me3 biva-
lency on hematopoietic genes in HSCs.INTRODUCTION
Mapping of epigenome modifications or chromatin regulator/
transcription factor binding in a pure cell population is critical
for basic and translational research. The ability to map epige-
nome changes in a cell population during development can
shed light on the steps by which different cell lineages establish
their transcriptional programs. Mapping the epigenome in a few
cells isolated from diseased or healthy tissuesmay allow the dis-
covery of specific disease-associated changes. Unfortunately,
because chromatin immunoprecipitation sequencing (ChIP-
seq) requiresmulti-step manipulations, DNA loss due to irrevers-
ible absorption or degradation has made it difficult to reliably
obtain high-quality mapping in only a few cells (Park, 2009).
ChIP-seq using standard methods requires nanograms of
DNA, and R106 cells are needed for reliable and high-quality
ChIP-seq (Park, 2009). Various strategies have been developed
to reduce the cell number needed. One method is to amplify the
cells derived from tissues in vitro. Although this is applicable forCell Repprogenitor/stem cell populations, it is not useful for dissected
post-mitotic cells. Culturing and proliferation in vitro may also
change progenitor/stem cells, potentially making the genome-
wide studies unrepresentative of cells in vivo. Several methods
have been developed to facilitate ChIP-seq using thousands or
tens of thousands of cells. One of them relies on increasing
DNA amplification cycles (Adli et al., 2010; Ng et al., 2013; Shan-
karanarayanan et al., 2011, 2012), whichmay introducemapping
bias, as low-abundance ChIP DNA may be underrepresented or
lost. Another method utilizes carrier proteins, chemicals, and/or
mRNA during ChIP (Zwart et al., 2013), but the absence of carrier
during post-ChIP processing still leads to significant DNA loss,
thereby compromising ChIP-seq quality.
A third method, called indexing-first ChIP-seq (iChIP-seq)
(Lara-Astiaso et al., 2014), uses barcoding and pooling of multi-
ple samples to study the epigenome in multiple hematopoietic
lineages. Although the method reduces DNA loss by sample
pooling, relying on sorting of fixed cells and sequential ChIP
may still lead to DNA loss. Additionally, the on-bead ligation of
adapters to chromatin fragments may reduce efficiency. Indeed,
10,000–20,000 sorted hematopoietic cells were used in these
iChIP-seq datasets (Lara-Astiaso et al., 2014). Finally, micro-
coccal nuclease (MNase)-based native ChIP (ultra-low-input
micrococcal nuclease-based native ChIP [ULI-NChIP]) was
also used for epigenetic mapping (Brind’Amour et al., 2015).
While the quality of ULI-NChIP-seq for some epigenetic modifi-
cations is reasonable, other modifications were not mapped,
indicating that the loss of ChIP DNA during manipulations may
result in variable outcomes. Here, we report a new ChIP-seq
method for high-fidelity genome-wide profiling using as few as
500 cells and report its applications.RESULTS
Recovery via Protection ChIP-Seq for 500 Cells
An effective way to protect DNA from loss during ChIP-seq is to
use agents that behave like DNA and co-purify with chromatin or
the DNA of interest during ChIP and library building. This would
prevent the loss of DNA due to nonspecific irreversible absorp-
tion and degradation by residual contaminating DNases. One
straightforward means is to use chromatin as a protection agent.
Although this would result in the presence of carrier DNA in the
sequencing library, the carrier DNA sequences can be easilyorts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1505
filtered out computationally after deep sequencing if they do not
map to the genome of interest. We compared various genomes
with one another, including mouse, human, Drosophila, yeast,
and bacteria. We generated artificial reads by scanning the
genome using a 50-bp sliding window. Using Bowtie (Langmead
et al., 2009) and allowing three mismatches, we mapped the
Drosophila sequences to other genomes.
Due to sequence conservation, many short reads derived from
the Drosophila genome mapped broadly to mammalian ge-
nomes (Figures S1A and S1B), so chromatin from Drosophila
and mammalian genomes cannot be used as protection agents
for one another. However, very few reads from S. cerevisiae
(yeast) and E. coliwere mapped to human, mouse, orDrosophila
genomes (Figures S1A and S1B). Importantly, over 90% of the
few short mapped reads are in rDNA or simple repeat regions
of target genomes. Since 30% of yeast chromatin carries
histone H3 lysine 4 trimethylation (H3K4me3) (Figures S1C and
S1D), and since commercial antibodies can successfully
ChIP H3K4me3 from yeasts to human, as proof of principle,
we used yeast chromatin as a carrier in the ChIP-seq of
H3K4me3 in a small number of mouse embryonic stem cells
(mESCs). We refer to this ChIP-seq as recovery via protection
(RP)-ChIP-seq.
We mixed formaldehyde cross-linked yeast (5 3 107) with
either 500 or 2,000 cross-linked mESCs. Following sonication,
antibody to H3K4me3 was used to ChIP both the yeast and
mESC chromatin using standard ChIP and library-building pro-
cedures. The similar patterns of H3K4me3 distribution around
the transcriptional start sites (TSS) between the ChIP-seq data-
sets from 500 or 2,000mESCs and the dataset from the standard
ChIP-seq of 107 mESCs (Jia et al., 2012) (Figure 1A) show that
RP-ChIP-seq successfully mapped H3K4me3 in 500 or 2,000
mESCs. Importantly, increasing read depth resulted in further
improvements of RP-ChIP-seq quality as indicated by an
increased correlation between RP-ChIP-seq and standard
ChIP-seq of 107 cells (Figure 1B). With 2.4 and 1.2 million map-
ped mouse reads, the correlation coefficient (R) between the
standard ChIP-seq of 107 mESCs and RP-ChIP-seq for 2,000
and 500 mESCs reached 0.976 and 0.952, respectively (Fig-
ure 1B). Analyses of specific chromatin regions also showed
that RP-ChIP-seq uncovered H3K4me3 peaks reliably (Figures
1C and 1D).
Favored Amplification RP-ChIP-Seq Reduces Read
Depth and Is Applicable to All Mapping Needs
The RP-ChIP-seq described above effectively preserved the
chromatin of interest, but it requires a substantial increase of to-
tal reads to obtain sufficient reads of the DNA of interest. It is not
universally applicable for ChIP-seq mapping of other epige-
nomes and transcription-factor binding, since yeast chromatin
does not share all epigenetic modifications as animal genomes.
We thus used a biotinylated synthetic DNA (biotin-DNA) to
replace the yeast chromatin. We designed 210-bp biotin-DNA
that does not map to Drosophila, mouse, or human genomes
(Figure S1A). Since only a few endogenous biotinylated proteins
have been found and none or few of them are associated with
chromatin (Jia et al., 2012; Kim et al., 2009; Rybak et al., 2005),
by mixing the biotin-DNA with chromatin, it was possible to re-1506 Cell Reports 13, 1505–1518, November 17, 2015 ª2015 The Aucovery the biotin-DNA and the chromatin of interest using strep-
tavidin beads and antibody-coupled protein G beads, respec-
tively. To inhibit amplification of biotin-DNA during library
building, a PCR amplification blocker oligo complementary to
the biotin-DNAwas designed to contain phosphorothioatemodi-
fication of the first three nucleotides at the 50 end to resist the
exonuclease activity of the PCR enzyme while a modified nucle-
otide carrying 3-carbon spacer at the 30 end was designed to
inhibit extension of the oligonucleotide by PCR (Figure 2A).
Indeed, when added at 0.25 mM during library amplification,
the blocker oligo reduced the amplification of the biotin-DNA
by over 99% (Figure S2A). We refer to this method as favored
amplification RP-ChIP-seq (FARP-ChIP-seq).
We mapped H3K4me3 in 500 mESCs using FARP-ChIP-seq.
Since H3K4me3 exhibits sharp peaks near promoters, the total
chromatin marked by H3K4me3 is lower compared to other his-
tonemodifications, which leads to difficulty in library building us-
ing low cell numbers. Indeed, the ULI-NChIP method obtained a
H3K27me3 library from1,000mESCs but was unsuccessful for
H3K4me3 mapping using the same cell number (Brind’Amour
et al., 2015). Successful H3K4me3 mapping indicates that our
method is also applicable for other histonemodifications. To effi-
ciently recover the small number of mESCs and their chromatin,
we added 5 3 108 bacteria as cell carrier to 500 mESCs fol-
lowed by fixation, wash, and sonication (Figure 2A). After ChIP
using biotin-DNA-bound Streptavidin beads and protein G
beads coupled to H3K4me3 antibodies, blocker oligos were
added during library building (Figure 2A). FARP-ChIP-seq re-
sulted in a 160-fold increase of mouse genomic DNA reads
compared to RP-ChIP-seq at the same read depth for 500
mESCs (Figure 2B; Table S1). The biological replicates were
highly consistent (Figure 2C; Table S1). The blocker oligo did
not affect the quality of the FARP-ChIP-seq data, because the
biological replicates were highly correlated (Spearman correla-
tion coefficient, R) with one another and with the standard
ChIP-seq of 107 mESCs (Figures 2C and 2D). The genome
browser view also shows a high correlation (Figure 2E). Themap-
ping of H3K27me3 in 1,000 mESCs by FARP-ChIP-seq also
showed this method to be highly reliable (Figures S2B and S2C).
RP-ChIP-Seq and FARP-ChIP-SeqOffer Superior Quality
Compared to All Reported Methods
Since several ChIP-seq methods for thousands or tens of thou-
sands of cells have been reported, we compared our methods
with these methods. For FARP-ChIP-seq, Nano-ChIP-seq, and
ULI-NChIP-seq of mESC H3K4me3 in low cell numbers, we
used the standard ChIP-seq dataset as a benchmark (Mikkelsen
et al., 2007). For LinDA-ChIP-seq of H3K4me3 in H3396 cells or
ERa ChIP-seq in MCF7 cells, we used the relevant million-cell
dataset reported in the same publications as benchmarks (Shan-
karanarayanan et al., 2011; Zwart et al., 2013). By comparing the
signal-to-noise ratio of different methods defined as the number
of reads falling into peak regions called from benchmark data-
sets, >40% reads of FARP-ChIP-seqmapped onto peaks similar
to the benchmark dataset, whereas all other methods had much
lower signal-to-noise ratios compared to their relevant bench-
marks (Table S1). Whole-genome correlation analyses using
non-overlapping 4-kb windows showed that the correlationthors
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Figure 1. RP-ChIP-Seq
(A) Heatmaps of H3K4me3 5 kb upstream and downstream of TSS in 107, 2,000, or 500 mESCs, rank ordered based on H3K4me3 in 107 mESCs.
(B) Contour plots (Spearman correlation coefficient, R) of H3K4me3 on promoters by RP-ChIP-seq in 500 or 2,000 mESCs at the indicated mouse reads and the
standard ChIP-seq in 107 mESCs at 163 million reads.
(C and D) Plots of H3K4me3 peaks on chromosome 17 (C) or the enlarged region boxed in red in C (D) using 500, 2,000, and 107 mESCs.
See also Figure S1 and Tables S1 and S2.coefficients between the two 500-cell H3K4me3 FARP-ChIP-
seq data and the benchmark are 0.901 and 0.902, which were
much higher than all other methods (Table S1). Thus, our method
did not bias the ChIP-seq signals.
A criterion for acceptable replicates adopted by the ENCODE
project is that at least 80% of the top 40% targets identified from
one ChIP-seq replicate should overlap with the targets ofCell Repanother replicate and vice versa (Landt et al., 2012). We defined
this as 80%precision and recall (see Supplemental Experimental
Procedures). Our two H3K4me3 FARP-ChIP-seq datasets
reached 99% precision and 99% recall for 500 cells when
compared to the 106 mESC H3K4me3 dataset (Mikkelsen
et al., 2007) (Figure 3A). The best-performing ULI-NChIP-seq
reached 99% precision and 92% recall using 5,000 cells,orts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1507
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Figure 2. Favored Amplification RP-ChIP-Seq
(A) Top: the biotin-DNA carrier annealed to the blocker oligo carrying a 30 modified 3-carbon spacer and 50 3 phosphorothioate modifications (asterisks). Bottom:
cells of interest (red) weremixedwith bacteria (blue), fixed, washed, and sonicated. Biotin-DNA bound to streptavidin beads and antibody-bound protein G beads
were added for ChIP.
(B) FARP-ChIP-seq resulted in increased ratios of mapped mouse reads to total reads.
(C and D) Contour plots (as log2 of the average read density within 2 kb upstream and downstream of TSS. Spearman correlation coefficient, R) between two
biological replicates of FARP-ChIP-seq in 500 mESCs (C) or between 500 mESC FARP-ChIP-seq and the 107 mESCs standard ChIP-seq.
(E) Enrichment at the indicated genes on chromosome 6 was mapped by the indicated methods.
See also Figure S2 and Tables S1 and S2.
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Figure 3. Comparisons among ChIP-Seq
Methods for Low Cell Numbers
(A) Precision-recall curves for H3K4me3 or ERa
peaks mapped by the indicated methods. Per-
centages of the top 40% peaks mapped by the
indicated methods that overlapped with the
respective peaks mapped by standard ChIP-seq in
R106 cells (x axis, precision) or mapped by stan-
dard ChIP-seq that overlapped with the respective
peaks mapped by the indicated methods (y axis,
recall). Curves are drawn by changing the p value
threshold used in calling peaks for indicated
method.
(B) ROC curve for H3K4me3 comparisons. True-
positive rate, the number of true-positive 2-kb re-
gions divided by the number of ‘‘true’’ regions
(25,000); false-positive rate, the number of false-
positive regions divided by the number of ‘‘false’’
regions.
(C) ROC curve H3K27me3 comparisons. True-
positive rate, the number of true-positive 5-kb re-
gions divided by the number of ‘‘true’’ regions
(25,000); false-positive rate: the number of false-
positive regions divided by the number of ‘‘false’’
regions.
The legend for ROC curves in (B) and (C) are or-
dered from best to worse AUC (area under curve)
values. See also Figure S3 and Tables S1 and S2.whereas the Nano-ChIP-seq (Adli et al., 2010) for H3K4me3 us-
ing 10,000 mESCs achieved only 70% precision and 70% recall
(Figure 3A). One of the LinDA-ChIP-seq datasets for 10,000
mESCs reached 80% precision and 80% recall, but its replicate
reached only 60% precision and 60% recall (Figure 3A). The
ChIP-seq of estrogen receptor a (ERa) in 10,000 MCF7 cells us-
ing mRNA and histone carriers (Zwart et al., 2013) achieved only
>20% precision and >20% recall when compared to the pub-
lished ERa ChIP-seq data using 20 million MCF7 cells (Zwart
et al., 2011) (Figure 3A). The details of peak numbers and total
length of peaks under different peak calling parameters are listed
in Table S2.
We also used the receiver-operating characteristic (ROC)
curve similar to those used in Nano-ChIP-seq (Adli et al., 2010)
to compare the H3K4me3 maps obtained by different methods.
We divided the genome into 2-kb non-overlapping windows and
used the top 25,000windowswith the highest read number in the
million-cell ChIP-seq datasets as ‘‘True.’’ By using different cut-
offs to calculate the true-positive and false-positive rates, we
plotted ROC curves for each method (Figure 3B), which showed
that our FARP-ChIP-seq method gave the best performance.
Next, we compared our FARP-ChIP-seq H3K27me3 datasets
with the dataset for 1,000 or 10,000 mESCs obtained using the
genome-amplification-based method (ChIP-WGA-seq) (Ng
et al., 2013). By calculating the correlation coefficient between
the ChIP-WGA-seq or FARP-ChIP-seq dataset and the ChIP-
seq dataset using 106 mESCs (Ng et al., 2013), we found coeffi-
cients of 0.729 (using 1,000 mESCs) and 0.782 (using 10,000
mESCs) for ChIP-WGA-seq (Figure S3), whereas the correlation
coefficient for FARP-ChIP-seq was 0.949 using 1,000 mESCs
(Figure S2B). Whole-genome correlation analysis using 10-kbCell Repnon-overlapping windows also showed that FARP-ChIP-seq
using 1,000 mESCs exhibits a whole-genome correlation coeffi-
cient of 0.890, which is much higher than the correlation coeffi-
cient of 0.547 or 0.585 obtained by ChIP-WGA-seq using
1,000 or 10,000 mESCs, respectively. ROC analysis for
H3K27me3 datasets using 5-kb windows showed that our
FARP-ChIP-seq datasets capture H3K27me3 signals better
than ChIP-WGA-seq (Figure 3C).
RP-ChIP-Seq Using One Mouse Lens Reveals
Age-Associated Epigenetic Changes
High-fidelity epigenome mapping in non-manipulated disease
tissue may identify candidate aging and disease-associated
epigenetic changes. Aging of the mammalian lens is associated
with cataract development (Li et al., 1995). Although age-associ-
ated alterations of the lens epithelial cells contribute to cataracts,
the mechanism is not fully understood. Since one adult mouse
lens consists of a population of 10,000 lens epithelial cells,
the RP-ChIP-seq method may allow accurate mapping of
H3K4me3 using a single dissected lens without having to
perform very deep sequencing. Indeed, mapping of H3K4me3
in a single lens dissected from young (30-day-old) or old
(>800-day-old) C57/BL6J mice using RP-ChIP-seq produced
highly consistent patterns in biological replicates of young and
old lenses (Figures 4A and 4B), indicating the robustness of the
method.
Since a recent report showed that broad H3K4me3 peaks
often marks important genes for the identity and function of cells
(Benayoun et al., 2014), we used MACS (Zhang et al., 2008) to
call peaks from young-lens H3K4me3 maps. The top five broad-
est peaks of young lens include known transcription factorsorts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1509
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Figure 4. RP-ChIP-Seq of H3K4me3 in One Dissected Mouse Lens
(A and B) Contour plots (Spearman correlation coefficient, R) between H3K4me3 on promoters obtained by RP-ChIP-seq in biological replicates of young (A) and
old single lens (B).
(C) Genome browser view of the representative top three broadest H3K4me3 peaks in young lens.
(D) GO-term analysis of the top broadest H3K4me3 peaks in young lens.
(E) Browser view ofCryaa andKcnab1 loci exhibiting aging-associated H3K4me3 increase in lens. The bar plot shows the relative H3K4me3 change at the two loci
quantified by the normalized number of total reads falling on the promoter peaks.
(F) Browser view of representative aging-associated H3K4me3 changes in lens.
See also Figure S4 and Table S3.important for eye development such as Pax6, Six3, and Tfap2a
(Figure 4C; Table S3). Gene Ontology (GO)-term analysis of the
top 5% broadest peaks showed enrichment of corresponding
genes in eye development and functions (Figure 4D; Table S3).
To uncover age-associated changes in lens epithelial cells, we
performed a complete comparison of H3K4me3 peaks between1510 Cell Reports 13, 1505–1518, November 17, 2015 ª2015 The Auyoung and old lenses and found 613 promoter peaks exhibiting
either increase or decrease of H3K4me3 upon aging (fold change
> 1.5, FDR < 0.05; see Supplemental Experimental Procedures
for details). To test whether the age-associated changes might
implicate genes in cataract formation, we searched published
cataract-associated SNPs discovered by genome-widethors
association studies (GWAS). A recent report identified two cata-
ract-associated SNPs in humans in the Cryaa and Kcnab1 loci
(Liao et al., 2014). Interestingly, we found that the corresponding
mouse gene loci showed a significant increase of H3K4me3 in
both peak height and width upon aging (Figure 4E). Further
studies of these two genes could shed light on whether their
age-associated H3K4me3 changes contribute toward cataract
development.
We further analyzed other genes exhibiting age-associated
H3K4me3 changes and found many with known or implicated
functions in lens development and homeostasis (Figure S4; Ta-
ble S4). For example, p57Kip2 (encoded by Cdkn1c) is known
to inhibit the cell cycle and promote lens epithelial differentiation
(Zhang et al., 1997). This gene had higher H3K4me3 in the 30-
day-old lens than in the aged lens (Figure 4F). This is consistent
with the known requirement of p57Kip2 in supporting lens growth
in the young mice (Jia et al., 2007). Since H3K4me3 is highly
correlated with gene expression (Jiang et al., 2011), the reduc-
tion of H3K4me3 on this gene upon aging suggests that
increased p57Kip2 expression may contribute to lens aging and
cataract development. Similarly, the reduction of H3K4me3 on
Hmga2 gene in aged lens (Figure 4F) suggests that Hmga2 is
not efficiently expressed. Interestingly, previous studies show
that Hmga2 negatively regulates aging by inhibiting expression
of the cell-cycle inhibitor p16Ink4a in neural stem cells (Nishino
et al., 2008). Consistently, we found an increase of H3K4me3
on the Ink4a promoter in aged lens (Figure 4F). This suggests
that the loss of Hmga2 expression could lead to p16Ink4a upre-
gulation, which could result in cell-cycle arrest and senescence
in lens epithelial cells.
Studies in humans suggest that the expression changes of
channel genes during aging could disrupt ion homeostasis,
which would contribute toward cataract formation (Segev
et al., 2005). Consistently, we found a significant enrichment of
channel genes with dramatic H3K4me3 loss upon aging (Fig-
ure S4C) (p < 0.01, hypergeometric test). One of these genes,
Scnn1a (encodes for the sodium channel, non-voltage-gated 1
alpha), has a significant decrease in expression in human cata-
racts (Hawse et al., 2003; Ruotolo et al., 2003). Additionally, we
found significant age-associated H3K4me3 changes in genes
involved in various signaling pathways or lens structure (Fig-
ure S4D; Table S4). Thus, the H3K4me3 datasets for old and
young lens can be used as resources for the further study of
eye development and aging.
FARP-ChIP-Seq Offers the Highest-Quality H3K4me3
Map to Date in Hematopoietic Stem Cell Subtypes
Sorted from One Mouse
Next, we tested whether FARP-ChIP-seq could accurately map
the epigenome of subtypes of hematopoietic stem cells (HSCs)
sorted from one mouse. HSCs support lifelong production of
all blood cells. Very little is known about genome-wide epige-
netic regulation during early hematopoiesis because of the small
numbers of cells that can be sorted from bone marrow (BM). For
example, only0.1%of BMcells are HSCs,which are defined as
lineage-negative (lin: CD3, CD4, CD8, B220, CD11b,
Gr1, Nk1.1, and Ter119), Sca1-positive (Sca1+), and c-Kit+
(LSK HSCs). The LSK HSCs (30,000/mouse) consist of threeCell Repfunctionally distinct subpopulations: long-term HSCs (LT-
HSCs), short-term HSCs (ST-HSCs), and multi-potent progeni-
tors (MPPs), which represent 0.007% (2,000/mouse), 0.04%
(12,000/mouse), and 0.05% (15,000/mouse) of total BMcells,
respectively (Yang et al., 2005). Three studies have mapped the
HSC epigenome. The Nano-ChIP-seq mapped H3K4me3,
H3K27me3, and H3K36me3 in 20,000 mixed-population LSK
HSCs (Adli et al., 2010). Of the two recent studies, one mapped
H3K4me3, H3K27me3, and H3K36me3 in subpopulations of
LSK HSCs pooled from many mice using standard ChIP-seq
(Sun et al., 2014), while the other mapped H3K4me1,
H3K4me2, H3K4me3, and H3K27ac in LT-HSCs, ST-HSCs,
and MPPs pooled from six mice ranging from 8 to 12 weeks
old using iChIP-seq (Lara-Astiaso et al., 2014).
Assuming that all the reported ChIP-seq qualities are high, the
epigenome maps obtained by pooling subpopulations of HSCs
from several mice at different ages or using mixed LSK HSCs
may not accurately determine the epigenome of LT-HSCs, ST-
HSCs, or MPPs. We thus applied FARP-ChIP-seq to map
H3K4me3 and H3K27me3 in LT-HSCs, ST-HSCs, or MPPs
sorted from individual 8-week-old C57BL/6J mice (see Supple-
mental Experimental Procedures). To avoid cross contamination
of HSC subtypes, we gated stringently during sorting and based
on the estimated cell numbers by flow cytometry, 1,500 LT-
HSCs, 6,000 ST-HSCs, and 10,000 MPPs could be sorted
from one mouse (Figures 5A and 5SA). Since flow cytometry
cannot accurately count the relatively rare LT-HSCs and ST-
HSCs in one mouse, we developed a method that accurately
determined the number of these cells in the input samples for
FARP-ChIP-seq to be 800–1,200 LT-HSCs and 1,200–1,500
ST-HSCs (Figures 5B and S5B; also see Supplemental Experi-
mental Procedures). For MPPs, we used one fourth of the total
sorted cells for one FARP-ChIP-seq, which corresponded to
2,000–2,500 cells.
We found highly consistent FARP-ChIP-seq maps for
H3K4me3 between biological replicates in the three HSC sub-
types (Figures 5C–5E). A multi-dimension scaling plot (MDS-
plot) showed good clustering of replicates (Figure 5F), indicating
that the H3K4me3 peaks are distinct in LT-HSC, ST-HSC, and
MPPs. The only reported maps of H3K4me3 in LT-HSC, ST-
HSC, and MPPs utilized iChIP-seq, in which the BM cells pooled
from several 8- to 12-week-oldmicewere first labeled, fixed, and
then sorted for the three HSC subtypes. iChIP-seq was per-
formed using 10,000–20,000 sorted LT-HSC, ST-HSC, or
MPPs. Since the iChIP-seq used the same markers to sort LT-
HSC, ST-HSC, and MPPs, we compared our FARP-ChIP-seq
maps to those of iChIP-seq.
We first determined whether the iChIP H3K4me3 dataset
could distinguish LT-HSCs, ST-HSCs, andMPPs. Only one sam-
ple for LT-HSCs and MPPs was available in the iChIP study.
Nonetheless, the MDS plot revealed that the two biological rep-
licates for ST-HSC iChIP-seq failed to cluster, whereas the bio-
logical replicates of the FARP-ChIP-seq datasets clustered
well (Figures 5F and 5G). Consistent with theMDS plot, no differ-
ential H3K4me3 peaks were identified among the iChIP-seq
H3K4me3 datasets obtained for LT-HSCs, ST-HSCs, and
MPPs, whereas hundreds of differential peaks were found in
the FARP-ChIP-seq datasets (see next section).orts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1511
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Figure 5. FARP-ChIP-Seq of HSC Subtypes
(A) FACS plots with the markers and gating used for sorting LSK HSCs, LT-HSCs, ST-HSCs, and MPPs.
(B) The number of sorted LT-HSCs and ST-HSCs used in FARP-ChIP-seq determined by low-depth genome sequencing.
(C–E) Contour plots (Spearman coefficient, R) between H3K4me3 on promoters obtained (plotted as log2 of the average read density within 2 kb upstream and
downstream of TSS) by FARP-ChIP-seq in two biological replicates of LT-HSCs (C), ST-HSCs (D), and MPPs (E).
(F and G) MDS plot of FARP-ChIP-seq (F) or iChIP-seq (G) H3K4me3 maps in LT-HSCs, ST-HSCs, and MPPs. Distances between biological replicates
(1 and 2) within and between HSC subtypes show the similarities and differences among the datasets. iChIP-seq of LT-HSCs and MPPs have no biological
replicate, while the ST-HSCs biological replicates (1 and 2) do not cluster together.
(H) A summary of FARP-ChIP-seq and iChIP-seq of H3K4me3 in LT-HSCs and ST-HSCs with the cell numbers, antibody sources, and library complexities.
(I) Genome browser view of representative iChIP-only H3K4me3 peaks in LT-HSCs that overlap with the iChIP H3K4me3 peaks in B cells but are absent from the
FARP-ChIP-seq of LT-HSCs.
See also Figure S5 and Tables S4 and S5.
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We next used the ‘‘preseq’’ software package (Daley and
Smith, 2013) to estimate the iChIP-seq H3K4me3 library
complexity based on the deposited datasets (Lara-Astiaso
et al., 2014). The iChIP library complexities for LT-HSCs, ST-
HSCs, and MPPs are 2.5–6.5M (million reads) (Figure 5H). If
the recovery rates of ChIP DNA were constant for different
numbers of input cells, this would translate to 250,000–
650,000 library complexity for 1,000 cells, which would suggest
that iChIP-seq might not perform well using low cell numbers.
We were unable to analyze the library complexity of the iChIP-
seq mapping of H3K4me3 using 500 BMDCs because the orig-
inal dataset was not available in the public database. By
contrast, our FARP-ChIP-seq library complexities for the HSC
subtypes ranged from 14M to 60M using 800–1,500 input cells
(Figure 5H). Since we used an H3K4me3 antibody different
from that used in the iChIP study, we repeated the FARP-
ChIP-seq using the same antibody used for iChIP-seq. The li-
brary complexity obtained using 1,500 ST-HSCs was 7.3M,
which was higher than the highest complexity of 6.4M obtained
by iChIP-seq of 10,000–20,000 cells (Figure 5H). This indicates
that FARP-ChIP-seq offers more accurate epigenome mapping
in fewer cells.
To ensure high recovery of live-sorted rare HSC subtypes dur-
ing fixation and washes, we used bacteria as cell carriers in
FARP-ChIP-seq, whereas a large number of labeled BM cells
were fixed, washed, and sorted for HSC subtypes in iChIP-
seq. Although fixing and washing large numbers of BM cells pre-
vents cell loss, fixation changes the fluorescence of cell surface
labels and is also not compatible with propidium iodide (PI) or
DAPI staining used for dead cell exclusion. Thus fixation could
result in increased impurity of the sorted cells. We reasoned
that lineage-signature based on H3K4me3 could allow us to
assess cell purity used in iChIP-seq and FARP-ChIP-seq. By
comparing the H3K4me3 datasets for LT-HSCs, we found
10,718 shared, 1,252 FARP-ChIP-only, and 4,963 iChIP-only
peaks. GO-term analyses of the FARP-ChIP-only peaks showed
no significant enrichment of genes belonging to any terms,
whereas the iChIP-only peaks were enriched for genes involved
in B cell activation and proliferation (Figure S5C) and include key
B cell regulators such as Pax5, Ebf1, Ikzf3, and Cd74 and B cell
marker genes such as Cd19 (Figure 5I), suggesting a potential B
cell contamination of the LT-HSCs in the iChIP-seq. Next, we
compared the iChIP-only H3K4me3 peaks in LT-HSCs to the to-
tal iChIP-seq H3K4me3 peaks determined for B cells in the same
study (Lara-Astiaso et al., 2014). Among the top 20%highest LT-
HSCs iChIP-only peaks, which are unlikely resulted from random
noise, 95% overlapped with the B cell H3K4me3 peaks. Similar
analysis suggests that one of the ST-HSC samples used in
iChIP-seq also had B cell contamination. These analyses
demonstrate that FARP-ChIP-seq allows high-quality epige-
nome mapping in a low number of sorted pure HSC subtypes
because it does not rely on the sorting of fixed cells and ensures
the recovery of very low amounts of ChIP DNA.
High-Quality H3K4me3 Mapping by FARP-ChIP-Seq
Offers a Resource for Studying HSC Subtypes
Since the broadest H3K4me3 peaks often mark genes important
for the function and identity of a given cell type (Benayoun et al.,Cell Rep2014), we further mined the H3K4me3 maps obtained by FARP-
ChIP-seq for LT-HSCs, ST-HSCs, and MPPs (Table S5). GO-
term analysis showed that all broad H3K4me3 peaks in
LT-HSCs, ST-HSCs, and MPPs were enriched in hematopoietic
functions (Figure S6). For example, genes important for HSC
regulation such as Meis1, Hlf, and Erg all exhibited broad
H3K4me3 peaks (Figure 6A) in all three HSC subtypes. Thus,
by looking for genes with broadest H3K4me3 peaks in our data-
sets, one may identify new candidate regulators of HSC for
further functional studies.
By comparing ST-HSCs and LT-HSCs, we identified 725 up-
and 788 downregulated H3K4me3 peaks (fold change > 1.5,
FDR < 0.05). Among the genes exhibiting increased H3K4me3
peaks in ST-HSCs, we found those involved in cell-cycle regula-
tion and DNA replication such as E2f8, Smc2, and Chek1 (Fig-
ure 6B). Consistently, previous RNA sequencing (RNA-seq)
showed an increased expression of genes that belong to these
functional groups (Cabezas-Wallscheid et al., 2014). Interest-
ingly, we found thatmultiple regulators of chromatin organization
such as Cbx5 and Suv39h1 exhibited increased H3K4me3 (Fig-
ure 6B), suggesting that ST-HSC may have more condensed
chromatin structure than LT-HSCs. GO-term analysis of differen-
tial promoter H3K4me3 peaks between LT-HSCs and ST-HSCs
also supports the functional differences in cell cycle and chro-
matin organization in these two HSC subtypes (Figure 6C).
When the H3K4me3 datasets between ST-HSCs and MPPs
were compared, we identified 878 up- and 881 downregulated
peaks (fold change > 1.5, FDR < 0.05) inMPPs. Among the genes
with downregulated H3K4me3, we found known regulators of
HSC generation, maintenance, or survival, such as Gata2 and
Tal1 (Figure 6D) (Porcher et al., 1996; Tsai and Orkin, 1997),
had the broadest peaks in LT-HSCs and ST-HSCs. This sug-
gests that H3K4me3 changes in these genes are responsible
for preparing MPPs for multi-lineage differentiation. However,
genes such as Ikzf1 and Dntt that are known to be required for
lymphoid lineage functions exhibited an increase in H3K4me3
in MPPs (McCaffrey et al., 1975; Reynaud et al., 2008). Interest-
ingly, GO-term analysis of differential promoter H3K4me3 peaks
further revealed enrichment of genes required for mRNA meta-
bolism and cell cycle in MPPs (Figure 6E). Taken together, the
high-quality H3K4me3 maps obtained by FARP-ChIP-seq pro-
vide useful resources for the study of LT-HSCs, ST-HSCs, and
MPPs.
A General Lack of H3K4me3/H3K27me3 Bivalency in
HSCs in Genes Required for Hematopoietic
Differentiation
The marking of genes required for lineage specification and
development by both H3K27me3 and H3K4me3 on their pro-
moters was first discovered in mESCs (Bernstein et al., 2006).
This so-called bivalent epigenetic mark is implicated in poising
developmental regulators for rapid up- or downregulation and
is thus considered to be important for lineage differentiation
(Bernstein et al., 2006). Several studies have suggested the ex-
istence of bivalent genes in other stem/progenitor cells, but the
coexistence of these marks on the same promoter within one
cell has been firmly established only in mESCs (Voigt et al.,
2012). Whether the reported bivalency for other stem/progenitororts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1513
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Figure 6. Comparison of H3K4me3 between HSC Subtypes
(A) Genome browser view of common broad H3K4me3 peaks on genes in the HSC subtypes.
(B–E) Genome browser view of H3K4me3 differences in genes in the HSC subtypes (B and D) and GO-term of genes with significant changes of promoter
H3K4me3 between indicated HSC subtypes (C and E). Green, red, or blue bars represent ST-HSC, LT-HSC, orMPP enrichedGO terms, respectively. No ST-HSC
enriched GO terms were found.
See also Figure S6 and Table S5.cells reflects true dual marking or cell heterogeneity remains
unclear.
The studies that reported bivalent genes in HSCs used total
LSK HSCs or purified subpopulations of LSK HSCs (Adli et al.,
2010; Sun et al., 2014; Weishaupt et al., 2010). Overall, 740–
2,260 bivalent genes were found in HSCs or its subtypes. Since
the biological replicates of FARP-ChIP-seq maps of H3K27me3
were highly consistent (Figures 7A–7C), we analyzed
H3K27me3/H3K4me3 bivalency using our datasets. We found
that LT-HSCs, ST-HSCs, and MPPs had only 302, 376, and
117 bivalent genes, respectively (Figures 7D–7F; Table S6).
Among these, Rhpn2, Zfp580, Rassf5, and Gata3 were reported
as bivalent genes previously (Sun et al., 2014; Weishaupt et al.,
2010) (Figure 7G). When analyzing how many of the known
mESC bivalent genes were resolved in the three HSC subtypes,
we found that 605–662 and 1,677–1,757 of them became1514 Cell Reports 13, 1505–1518, November 17, 2015 ª2015 The AuH3K4me3-only or H3K27me3-only genes, respectively.
Whereas 58–184 of the mESC bivalent genes remained bivalent,
257–468 of them had neither modification in the three HSC sub-
types (Figure 7H). Importantly, the bivalent genes uncovered by
FARP-ChIP-seq are not implicated in regulating hematopoietic
lineage development (Table S6) and GO-term analysis revealed
no significant enrichment of pathway genes. Moreover, when
all bivalent genes were combined in the three HSC subtypes,
the 562 total bivalent genes identified by FARP-ChIP-seq were
still smaller than the number previously reported for HSCs.
To confirm whether H3K4me3/H3K27me3 bivalency is not
used to mark the genes required for differentiation of HSCs,
we analyzed the bivalent genes reported previously by focusing
on the dataset obtained for a subpopulation of LSK HSCs
defined as SP (side population) and CD150+ (SP-CD150+-LSK
HSCs) (Sun et al., 2014). (Another dataset mapped bythors
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Figure 7. Genes for Hematopoietic Lineage Differentiation Are Not Generally Marked by H3K4me3/HK27me3 Bivalency in HSCs
(A–C) Contour plots (Spearman correlation coefficient, R) between H3K27me3 (plotted as log2 of the average read density within 5 kb upstream and downstream
of TSS) on promoters obtained by FARP-ChIP-seq in biological replicates of the HSC subtypes.
(D–F) Scatterplots of H3K4me3 and H3K27me3 enrichment (plotted as log2 of the average read density within 2 kb upstream and downstream of TSS) based on
FARP-ChIP-seq in the HSC subtypes.
(G) Genome browser view of bivalent genes found by FARP-ChIP-seq in the HSC subtypes and by previous studies. Rectangles outline the bivalent promoters.
(H) Bar plot showing how bivalent genes found in mESCs are resolved in HSC subtypes mapped by FARP-ChIP-seq.
See also Figure S7 and Tables S6 and S7.Nano-ChIP-seq was for more heterogeneous LSK HSCs; Adli
and Bernstein, 2011.) Since no bivalent gene list was provided
in the mapping of the SP-CD150+-LSK HSCs (Sun et al., 2014),
we first used our criteria to identify bivalent genes in the pub-
lished dataset. We found 1,940 promoters with both H3K4me3
and H3K27me3 enrichment in SP-CD150+-LSK HSCs, similarCell Repto the reported number of bivalent genes (Sun et al., 2014).
Among these, 210 overlapped with the bivalent genes found in
our dataset, whereas the remaining genes had only H3K27me3
enrichment (91.7%, 1,587 of 1,730) in our dataset. Strikingly,
GO-term analyses revealed that the 1,940 bivalent genes were
not enriched for hematopoietic differentiation or developmentorts 13, 1505–1518, November 17, 2015 ª2015 The Authors 1515
(Table S7) but were instead enriched for the differentiation/devel-
opment of nervous system followed by epithelia, skeletal sys-
tem, kidney, mesenchymal cells, urogenital system, heart, and
pancreas (Figure S7A). Among the 1,940 bivalent genes, we
selected 300 with the strongest H3K4me3 and compared
them to the available RNA-seq datasets of the hematopoietic lin-
eages and found that only 72 were expressed in at least one line-
age (Figure S7B) (Lara-Astiaso et al., 2014). This is consistent
with the idea that genes required for non-hematopoietic lineage
development are silenced in HSCs and the differentiated he-
matopoietic lineages. Based on our dataset, most of the 1,940
bivalent genes are marked only by the repressive H3K27me3,
so these analyses further confirm that H3K4me3 and
H3K27me3 are not used to mark the poised state of genes
required for hematopoietic lineage differentiation in HSCs.
DISCUSSION
The ChIP-seq method reported here is based on the idea that if a
rare cell population is not lost during the initial fixation and wash
steps, and if chromatin loss is minimized during ChIP and library
building, it should be possible to recover low-abundance DNA
without increasing DNA amplification cycles. Although we report
only epigenome mapping using FARP-ChIP-seq, the general
principle of using synthetic DNA as carrier is applicable to all
ChIP-seq, genomic DNA-seq, and RNA-seq needs when a sin-
gle cell or a small number of cells are used. The presence of bac-
teria DNA and bio-DNA in the final sequencing library calls for
5-fold increase in read depth for FARP-ChIP-seq of 500 cells,
and read depth is decreased as cell number used increases.
Considering that FARP-ChIP-seq offers the highest-fidelity
mapping compared to all other methods for low cell numbers,
this modest increase in sequencing depth justifies its
application.
Various carrier approaches have been employed to ensure the
recovery of small amounts of DNA or RNA in different applica-
tions. In the specific case of ChIP-seq, we show that DNA or
chromatin carrier ensures co-purification of carriers with the
DNA of interest in each step. Since the carrier has the same char-
acteristics as the DNA of interest, it can effectively occupy
nonspecific and irreversible DNA binding sites present on all sur-
faces and can also saturate contaminating DNases. Here, we
show that RP-ChIP-seq and FARP-ChIP-seq allows accurate
mapping of epigenome in as few as 500 cells. Although bacteria
DNA was not pulled down in our ChIP design, substantial
nonspecific bacteria DNA was carried over and amplified in the
library building step, which contributed to the increased read
depth needed. Additional improvements, such as treating bacte-
ria with DNA crosslinkers, and the use of microfluidic techniques
(Aguilar and Craighead, 2013) should further reduce read depth
and cell number needed in a high-throughput format.
Our proof-of-concept RP-ChIP-seq of H3K4me3 analyses us-
ing one dissectedmouse lens demonstrate the usefulness of ob-
taining epigenomemaps of young and old tissues. The high-data
quality have allowed us to identify age-associated H3K4me3
changes in mouse lens. Among the genes that exhibit age-asso-
ciated changes in H3K4me3, we have identified both known and
possible candidate genes whose deregulation upon aging could1516 Cell Reports 13, 1505–1518, November 17, 2015 ª2015 The Aucontribute to cataracts. For example, two genes, Cryaa and
Kcnab1, which contain cataract-associated SNPs based on
recent humanGWAS, exhibited significant age-associated upre-
gulation of H3K4me3 in mouse lens. It will be interesting to
further study whether the expression of these two genes is
increased in the lens of cataract patients, because it could reveal
whether the identified SNPs directly contribute to cataract
development.
The FARP-ChIP-seq allowed us to reveal the high-quality
maps of H3K4me3 and H3K27me3 using low number of LT-
HSCs, SH-HSCs, and MPPs compared to previously published
datasets. By using pure cell populations, we found fewer
H3K4me3/H3K27me3 bivalent genes in HSCs than previously
reported. More importantly, the bivalent genes found in both
our study and the reported studies are not involved in hemato-
poietic lineage specification. This shows that H3K4me3/
H3K27me3 bivalency is unlikely to be the mechanism used for
poising lineage-specific gene expression in HSCs. However, it
is possible that other mechanisms are used to poise genes for
expression. For example, in multi-potential hematopoietic cells
such as the established EML cell line, hematopoietic-specific
genes may be poised by H3K4me2-positive and H3K4me3-
negative marks (Orford et al., 2008). RNA polymerase II pausing
on promoters may also poise genes for expression (Puri et al.,
2015). The FARP-ChIP-seq strategy reported here should aid
in the further study of how HSCs poise genes for lineage
differentiation.
The methods reported here should allow large-scale epige-
nome association studies using pure cell populations from
patients or animalmodels. Reduced cell heterogeneity should in-
crease the success rate of discovering epigenetic changes that
are relevant to either developmental or disease processes. The
feasibility of mapping the epigenome of dissected tissues or
sorted cells will allow improved understanding of epigenetic
changes during each stage of organ and tissue building.
Coupling such information with gene expression studies should
greatly enhance our understanding of the developmental pro-
cesses. The disease-associated epigenetic changes mapped
with dissected tissues, in conjunction with GWAS, should greatly
improve the accuracy and power of biomarker discovery and
disease diagnosis.
EXPERIMENTAL PROCEDURES
Mouse ESCs and Culture
V6.5 mESCs were maintained in DMEM supplemented with 15% fetal calf
serum, 0.1 mM b-mercaptoethanol, 2 mM L-glutamine, 0.1 mM nonessential
amino acids, 1,000U/ml recombinant leukemia inhibitory factor (LIF; Millipore),
and 30 U/ml penicillin/streptomycin (the ESC medium) on plates coated with
gelatin (Millipore).
Mouse Lens and HSC Subtype Isolation
All mouse procedures were in accordance with the guidelines of the Carnegie
Institution Animal Care and Use Committee. For detailed methods, see Sup-
plemental Experimental Procedures.
ChIP-Seq
Standard ChIP-seq follows the manufacturer’s instructions with modifications
detailed in Supplemental Experimental Procedures. The RP-ChIP-seq and
FARP-ChIP-seq protocols involve the addition of yeast or bacteria as cellthors
carriers to allow the recovery of the low number of cells of interest. Bio-DNA
was added as carrier during ChIP. Blocker oligo was added to prevent the
amplification of the Bio-DNA during library building. For detailed ChIP proto-
cols, see Supplemental Experimental Procedures.
Quality Filtering, Mapping, and Analyses of All ChIP-Seq Datasets in
This Study
For RP-ChIP-seq and FARP-ChIP-seq libraries, reads were filtered using the
quality of multiplexing indices before mapping to prevent contamination by
erroneous de-multiplexing. Reads with an average index quality below 30
were discarded (Kircher et al., 2012). The reads were then mapped to mouse
genome (mm9) by Bowtie, allowing two mismatches per read. Only uniquely
mapped reads were retained. The mapped reads were further mapped to car-
rier genome or biotin-DNA sequences by Bowtie allowing three mismatches,
and reads mapped to the carrier genome or biotin-DNA was discarded. For
detailed data analyses, see Supplemental Experimental Procedures.
Comparison of ChIP-Seq Qualities among Different Methods
To compare different ChIP-seq methods, we used multiple criteria as detailed
in Supplemental Experimental Procedures.
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